Supernus Pharmaceuticals Quote - 0LB2

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

55.00

Bid

0.00

Ask

0.00

Volume

101

0.00 Day's Range 0.00

55.00 52 Week Range 55.00

Market Cap

3.037B

Previous Close

55.00

Open

Last Trade

100

31.525

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

203

Shares Outstanding

55,219,000

Dividend Yield

PE Ratio

23.97

Earnings Per Share (EPS)

1.34

Revenue

667.93M

Net Profit

73.87M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.supernus.com

Headquarters

Wilmington, Delaware, USA

Founded

Supernus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0LB2. The last closing price for Supernus Pharmaceuticals was US$55. Over the last year, Supernus Pharmaceuticals shares have traded in a share price range of US$ 55.00 to US$ 55.00.

Supernus Pharmaceuticals currently has 55,219,000 shares outstanding. The market capitalization of Supernus Pharmaceuticals is US$3.04 billion. Supernus Pharmaceuticals has a price to earnings ratio (PE ratio) of 23.97.

No news to show yet.

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	55	55	55	11	55	DE
4	55	55	55	222	55	DE
12	55	55	55	203	55	DE
26	55	55	55	235	55	DE
52	55	55	55	159	55	DE
156	55	55	55	74	55	DE
260	55	55	55	70	55	DE

0LB2 - Frequently Asked Questions (FAQ)

What is the current Supernus Pharmaceuticals share price?

The current share price of Supernus Pharmaceuticals is US$ 55.00

How many Supernus Pharmaceuticals shares are in issue?

Supernus Pharmaceuticals has 55,219,000 shares in issue

What is the market cap of Supernus Pharmaceuticals?

The market capitalisation of Supernus Pharmaceuticals is USD 3.04B

What is the 1 year trading range for Supernus Pharmaceuticals share price?

Supernus Pharmaceuticals has traded in the range of US$ 55.00 to US$ 55.00 during the past year

What is the PE ratio of Supernus Pharmaceuticals?

The price to earnings ratio of Supernus Pharmaceuticals is 23.97

What is the cash to sales ratio of Supernus Pharmaceuticals?

The cash to sales ratio of Supernus Pharmaceuticals is 2.65

What is the reporting currency for Supernus Pharmaceuticals?

Supernus Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Supernus Pharmaceuticals?

The latest annual turnover of Supernus Pharmaceuticals is USD 667.93M

What is the latest annual profit for Supernus Pharmaceuticals?

The latest annual profit of Supernus Pharmaceuticals is USD 73.87M

What is the registered address of Supernus Pharmaceuticals?

The registered address for Supernus Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Supernus Pharmaceuticals website address?

The website address for Supernus Pharmaceuticals is www.supernus.com

Which industry sector does Supernus Pharmaceuticals operate in?

Supernus Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
APQApq Global Limited	1.25p (316.67%)	170.41k
CTAICatenai Plc	0.255p (50.00%)	71.47M
ATMAndrada Mining Limited	2.775p (42.31%)	73.72M
PXCPhoenix Copper Limited	4.75p (31.03%)	6.07M
MET1Metals One Plc	1.025p (28.13%)	9.08M
PREMPremier African Minerals Limited	0.01275p (-32.89%)	4.11B
FMETFulcrum Metals Plc	6.50p (-25.71%)	915.95k
AFPAfrican Pioneer Plc	0.825p (-14.95%)	368.36k
VRCIVerici Dx Plc	2.875p (-14.81%)	2.28M
SCSPSeed Capital Solutions Plc	0.75p (-14.29%)	269.85k
PREMPremier African Minerals Limited	0.01275p (-32.89%)	4.11B
VELAVela Technologies Plc	0.0028p (3.70%)	1.47B
TRPTower Resources Plc	0.023p (-4.17%)	519.52M
SYMESupply@me Capital Plc	0.0034p (-11.69%)	420.2M
ORCPOracle Power Plc	0.0165p (-8.33%)	403.8M